[HTML][HTML] Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices
E Petrosky, JA Bocchini Jr, S Hariri, H Chesson… - MMWR Morb Mortal …, 2015 - cdc.gov
Methods From October 2013 to February 2015, the ACIP HPV Vaccine Work Group
reviewed clinical trial data assessing the efficacy, immunogenicity, and safety of 9vHPV …
reviewed clinical trial data assessing the efficacy, immunogenicity, and safety of 9vHPV …
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition …
LE Markowitz, S Hariri, C Lin, EF Dunne… - The Journal of …, 2013 - academic.oup.com
Background. Human papillomavirus (HPV) vaccination was introduced into the routine
immunization schedule in the United States in late 2006 for females aged 11 or 12 years …
immunization schedule in the United States in late 2006 for females aged 11 or 12 years …
The estimated lifetime probability of acquiring human papillomavirus in the United States
HW Chesson, EF Dunne, S Hariri… - Sexually transmitted …, 2014 - journals.lww.com
Background Estimates of the lifetime probability of acquiring human papillomavirus (HPV)
can help to quantify HPV incidence, illustrate how common HPV infection is, and highlight …
can help to quantify HPV incidence, illustrate how common HPV infection is, and highlight …
Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003–2006
S Hariri, ER Unger, M Sternberg… - Journal of Infectious …, 2011 - academic.oup.com
Background. Genital human papillomaviruses (HPV) include> 40 sexually transmitted
viruses. Most HPV infections do not progress to disease, but infection with certain types of …
viruses. Most HPV infections do not progress to disease, but infection with certain types of …
Prevalence of HPV after introduction of the vaccination program in the United States
LE Markowitz, G Liu, S Hariri, M Steinau, EF Dunne… - …, 2016 - publications.aap.org
BACKGROUND: Since mid-2006, human papillomavirus (HPV) vaccination has been
recommended for females aged 11 to 12 years and through 26 years if not previously …
recommended for females aged 11 to 12 years and through 26 years if not previously …
Population impact of HPV vaccines: summary of early evidence
S Hariri, LE Markowitz, EF Dunne, ER Unger - Journal of Adolescent Health, 2013 - Elsevier
Human papillomavirus (HPV) vaccines are available in the United States and around the
world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV …
world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV …
Post-licensure monitoring of HPV vaccine in the United States
LE Markowitz, S Hariri, ER Unger, M Saraiya, SD Datta… - Vaccine, 2010 - Elsevier
Post-licensure evaluation of vaccines plays an important role in monitoring the progress of
immunization programs, demonstrating population impact of vaccines, and providing data …
immunization programs, demonstrating population impact of vaccines, and providing data …
[HTML][HTML] Family history of type 2 diabetes: a population-based screening tool for prevention?
Purpose: To evaluate the use of self-reported family medical history as a potential screening
tool to identify people at-risk for diabetes. Methods: The HealthStyles 2004 mail survey …
tool to identify people at-risk for diabetes. Methods: The HealthStyles 2004 mail survey …
Epidemiology of human immunodeficiency virus in the United States
S Hariri, MT McKenna - Clinical Microbiology Reviews, 2007 - Am Soc Microbiol
The human immunodeficiency virus (HIV) epidemic emerged in the early 1980s with HIV
infection as a highly lethal disease among men who have sex with men and among frequent …
infection as a highly lethal disease among men who have sex with men and among frequent …
[HTML][HTML] National and state vaccination coverage among adolescents aged 13–17 years—United States, 2012
CR Curtis, D Yankey, J Jeyarajah, C Dorell… - MMWR Morb Mortal …, 2013 - cdc.gov
At ages 11 through 12 years, the Advisory Committee on Immunization Practices (ACIP)
recommends that preteens receive 1 dose of tetanus, diphtheria, and acellular pertussis …
recommends that preteens receive 1 dose of tetanus, diphtheria, and acellular pertussis …